InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Wave Life Sciences, Inc.

WVE Clue Score51
United States Fiscal year ends December CIK 0001631574 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

50
Insider
Date
Role
Action
Shares
Price
Amount
Chandra Vargeese
9 Feb 2026
See Remarks
Sell
3,228
$13.45
$43.42K
Chris Francis
9 Feb 2026
See Remarks
Sell
1,883
$13.45
$25.33K
Paul Bolno
9 Feb 2026
President and CEO
Sell
10,480
$13.45
$140.96K
Kyle Moran
9 Feb 2026
Chief Financial Officer
Sell
3,588
$13.45
$48.26K
Kyle Moran
16 Feb 2023
Chief Financial Officer
Sell
9,729
$4.04
$39.31K
Chris Francis
16 Feb 2023
See Remarks
Sell
10,258
$4.03
$41.34K
Paul Bolno
16 Feb 2023
President and CEO
Sell
29,400
$4.04
$118.78K
Chandra Vargeese
16 Feb 2023
See Remarks
Sell
10,249
$4.03
$41.30K
Chris Francis
5 May 2022
See Remarks
Sell
10,867
$1.72
$18.69K
Michael A. Panzara
5 May 2022
See Remarks
Sell
16,714
$1.72
$28.75K
Kyle Moran
5 May 2022
Chief Financial Officer
Sell
5,021
$1.72
$8.64K
Paul Bolno
5 May 2022
President and CEO
Sell
33,501
$1.72
$57.62K
Chandra Vargeese
5 May 2022
See Remarks
Sell
16,714
$1.72
$28.75K
Michael A. Panzara
16 Feb 2022
See Remarks
Sell
10,603
$2.31
$24.49K
Paul Bolno
16 Feb 2022
President and CEO
Sell
33,150
$2.32
$76.91K
Chandra Vargeese
16 Feb 2022
Chief Technology Officer
Sell
10,603
$2.32
$24.60K
Chris Francis
16 Feb 2022
See Remarks
Sell
10,123
$2.31
$23.38K
Kyle Moran
16 Feb 2022
Chief Financial Officer
Sell
9,204
$2.31
$21.26K
Kyle Moran
16 Feb 2021
Chief Financial Officer
Sell
1,722
$10.57
$18.20K
Chandra Vargeese
16 Feb 2021
Chief Technology Officer
Sell
3,145
$10.57
$33.24K
Michael A. Panzara
16 Feb 2021
See Remarks
Sell
2,929
$10.57
$30.96K
Paul Bolno
16 Feb 2021
President and CEO
Sell
11,205
$10.57
$118.44K
Chris Francis
16 Feb 2021
See Remarks
Sell
2,698
$10.57
$28.52K
Chandra Vargeese
18 Feb 2020
Senior VP, Drug Discovery
Sell
3,188
$7.85
$25.03K
Chris Francis
18 Feb 2020
See Remarks
Sell
2,708
$7.85
$21.26K
Paul Bolno
18 Feb 2020
President and CEO
Sell
11,451
$7.85
$89.89K
Michael A. Panzara
18 Feb 2020
Chief Medical Officer
Sell
2,981
$7.85
$23.40K
David G Gaiero
3 Feb 2020
Interim CFO
Sell
651
$7.00
$4.56K
Gregory L. Verdine
20 Nov 2019
Director
Sell
2,609
$32.74
$85.42K
Gregory L. Verdine
20 Nov 2019
Director
Sell
3,400
$31.59
$107.41K
Gregory L. Verdine
20 Nov 2019
Director
Sell
24,030
$30.27
$727.39K
Michael A. Panzara
5 Jul 2019
Chief Medical Officer
Sell
445
$27.26
$12.13K
Michael A. Panzara
5 Jul 2019
Chief Medical Officer
Sell
2,613
$26.88
$70.24K
Michael A. Panzara
11 Mar 2019
Franchise Lead, Neurology
Sell
7,000
$48.00
$336.00K
Chris Francis
19 Feb 2019
See Remarks
Sell
1,709
$36.84
$62.96K
Chandra Vargeese
19 Feb 2019
Senior VP, Drug Discovery
Sell
2,055
$36.84
$75.71K
Paul Bolno
19 Feb 2019
President and CEO
Sell
119
$37.47
$4.46K
Paul Bolno
19 Feb 2019
President and CEO
Sell
7,614
$36.38
$277.00K
Michael A. Panzara
19 Feb 2019
Franchise Lead, Neurology
Sell
1,837
$36.84
$67.67K
Keith Regnante
19 Feb 2019
Chief Financial Officer
Sell
1,298
$36.84
$47.82K
Gregory L. Verdine
14 Nov 2018
Director
Sell
4,300
$39.52
$169.94K
Gregory L. Verdine
14 Nov 2018
Director
Sell
10,700
$38.59
$412.91K
Keith Regnante
16 Feb 2018
Chief Financial Officer
Sell
316
$51.85
$16.38K
Michael A. Panzara
16 Feb 2018
Franchise Lead, Neurology
Sell
511
$52.10
$26.62K
Paul Bolno
16 Feb 2018
President and CEO
Sell
2,200
$51.62
$113.56K
Paul Bolno
16 Feb 2018
President and CEO
Sell
514
$51.01
$26.22K
Masaharu Tanaka
18 Sep 2017
Director
Sell indirect
6,362
$24.19
$153.90K
Masaharu Tanaka
15 Sep 2017
Director
Sell indirect
14,385
$24.22
$348.40K
Michael A. Panzara
12 Jul 2017
Franchise Lead, Neurology
Sell
7,414
$16.67
$123.62K
Masaharu Tanaka
29 Mar 2017
Director
Sell indirect
433,825
$24.91
$10.81M
Show all 166 transactions →

What was left out

Form 4 filings counted 234
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 74
Sales at will 50
Transactions with no price 0
Shares from compensation/vesting 9,171,525
Sales filed before the plan box existed 46
History held since 18 Nov 2015